Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
Clinical trial NCT02343172 · COMPLETED
Trial details
- NCT number
- NCT02343172
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-13
- Primary completion
- 2019-10-16
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.